RNF115 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.728800E-01
Normal-vs-Stage2
5.845400E-01
Normal-vs-Stage3
3.993700E-02
Normal-vs-Stage4
2.328600E-01
Stage1-vs-Stage2
9.663400E-01
Stage1-vs-Stage3
1.435570E-01
Stage1-vs-Stage4
7.707600E-02
Stage2-vs-Stage3
1.662200E-01
Stage2-vs-Stage4
3.307500E-02
Stage3-vs-Stage4
1.086190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.576400E-01
Normal-vs-AfricanAmerican
4.075200E-01
Normal-vs-Asian
2.918000E-01
Caucasian-vs-AfricanAmerican
8.606400E-02
Caucasian-vs-Asian
2.424800E-01
AfricanAmerican-vs-Asian
3.792000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.385600E-01
Normal-vs-Female
6.482600E-01
Male-vs-Female
4.622200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.308000E-02
Normal-vs-Age(41-60Yrs)
8.429600E-01
Normal-vs-Age(61-80Yrs)
5.100600E-01
Normal-vs-Age(81-100Yrs)
3.463000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.370200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.337600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.234800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.618100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.852000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.084000E-01
Normal-vs-Daily Drinker
1.605350E-01
Normal-vs-Weekly Drinker
8.937600E-01
Normal-vs-Occasional Drinker
7.836400E-01
Normal-vs-Social Drinker
8.911800E-01
Non Drinker-vs-Daily Drinker
2.843600E-01
Non Drinker-vs-Weekly Drinker
1.902840E-01
Non Drinker-vs-Occasional Drinker
1.683240E-01
Non Drinker-vs-Social Drinker
3.119800E-01
Daily Drinker-vs-Weekly Drinker
5.898000E-02
Daily Drinker-vs-Occasional Drinker
3.503600E-02
Daily Drinker-vs-Social Drinker
8.240300E-02
Weekly Drinker-vs-Occasional Drinker
8.840200E-01
Weekly Drinker-vs-Social Drinker
9.726000E-01
Occasional Drinker-vs-Social Drinker
9.247400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.621600E-01
Normal-vs-Grade 2
7.688400E-01
Normal-vs-Grade 3
7.501600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.200010E-01
Grade 1-vs-Grade 3
1.205040E-01
Grade 1-vs-Grade 4
6.621600E-01
Grade 2-vs-Grade 3
6.979800E-01
Grade 2-vs-Grade 4
7.688400E-01
Grade 3-vs-Grade 4
7.501600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.645000E-01
Normal-vs-NonDiabetic
4.997400E-01
Diabetic-vs-NonDiabetic
5.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.667200E-01
Normal-vs-NoPancreatitis
5.074800E-01
Pancreatitis-vs-NoPancreatitis
8.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.674200E-01
Normal-vs-N1
6.019600E-01
N0-vs-N1
9.407200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.196600E-01
Normal-vs-TP53-NonMutant
7.544600E-01
TP53-Mutant-vs-TP53-NonMutant
9.492600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
